EARNEST Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-208
Closed -$2.88K 905
2023
Q3
$2.88K Hold
208
﹤0.01% 937
2023
Q2
$2.49K Hold
208
﹤0.01% 964
2023
Q1
$2.43K Hold
208
﹤0.01% 958
2022
Q4
$3.5K Hold
208
﹤0.01% 885
2022
Q3
$2K Hold
208
﹤0.01% 996
2022
Q2
$3K Hold
208
﹤0.01% 938
2022
Q1
$3K Hold
208
﹤0.01% 961
2021
Q4
$2K Hold
208
﹤0.01% 1045
2021
Q3
$2K Hold
208
﹤0.01% 1044
2021
Q2
$2K Hold
208
﹤0.01% 1050
2021
Q1
$1K Hold
208
﹤0.01% 1139
2020
Q4
$1K Hold
208
﹤0.01% 1131
2020
Q3
$1K Hold
208
﹤0.01% 1092
2020
Q2
$1K Hold
208
﹤0.01% 1073
2020
Q1
$0 Hold
208
﹤0.01% 1154
2019
Q4
$2K Hold
208
﹤0.01% 1018
2019
Q3
$2K Hold
208
﹤0.01% 1004
2019
Q2
$2K Hold
208
﹤0.01% 1016
2019
Q1
$3K Hold
208
﹤0.01% 937
2018
Q4
$2K Hold
208
﹤0.01% 992
2018
Q3
$4K Hold
208
﹤0.01% 868
2018
Q2
$4K Hold
208
﹤0.01% 863
2018
Q1
$4K Hold
208
﹤0.01% 837
2017
Q4
$5K Buy
+208
New +$4.31K ﹤0.01% 755
2017
Q1
Sell
-208
Closed -$6K 747
2016
Q4
$6K Buy
+208
New +$5.14K ﹤0.01% 642

Other funds holding PTEN

EARNEST Partners's PTEN Position: Q4 2023 in Review

EARNEST Partners sold out of Patterson-UTI (PTEN) in Q4 2023, closing a stake of 208 shares — an estimated $2.88K sold.

EARNEST Partners first reported a position in PTEN in Q4 2016 and held it in 25 quarters. The position peaked at $6K in Q4 2016. 359 funds tracked by Wall St. Rank hold PTEN as of Q4 2023.

  • EARNEST Partners reported no remaining Patterson-UTI position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 208 Patterson-UTI shares in Q4 2023, an estimated $2.88K.
  • EARNEST Partners first reported a position in Patterson-UTI in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Patterson-UTI position peaked at $6K in Q4 2016.
  • 359 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.